 |
Previous Article | Next Article 
The Journal of Neuroscience, August 1, 1999, 19(15):6538-6548
Caveolin-3 Upregulation Activates -Secretase-Mediated
Cleavage of the Amyloid Precursor Protein in Alzheimer's Disease
Kazutoshi
Nishiyama1,
Bruce D.
Trapp1,
Tsuneya
Ikezu1,
Richard M.
Ransohoff1,
Taisuke
Tomita2,
Takeshi
Iwatsubo2,
Ichiro
Kanazawa3,
Karen K.
Hsiao4,
Michael P.
Lisanti5, and
Takashi
Okamoto1
1 Department of Neurosciences, The Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, Ohio,
2 Faculty of Pharmaceutical Sciences, Tokyo University,
Tokyo, Japan, 3 Division of Neuroscience, Graduate School
of Medicine, Tokyo University, Tokyo, Japan, 4 Department
of Neurology, University of Minnesota, Minneapolis, Minnesota, and
5 Department of Molecular Pharmacology and The Einstein
Cancer Center, Albert Einstein College of Medicine, Bronx, New York
Here, we investigate the involvement of caveolins in the
pathophysiology of Alzheimer's disease (AD). We show dramatic
upregulation of caveolin-3 immunoreactivity in astroglial cells
surrounding senile plaques in brain tissue sections from authentic AD
patients and an established transgenic mouse model of AD. In addition, we find that caveolin-3 physically interacts and biochemically colocalizes with amyloid precursor protein (APP) both in
vivo and in vitro. Interestingly, recombinant
overexpression of caveolin-3 in cultured cells stimulated
-secretase-mediated processing of APP. Immunoreactivities of APP
and presenilins were concomitantly increased in caveolin-3-positive
astrocytes. Because the presenilins also form a physical complex with
caveolin-3, caveolin-3 may provide a common platform for APP and the
presenilins to associate in astrocytes. In AD, augmented expression of
caveolin-3 and presenilins in reactive astrocytes may alter APP
processing, leading to the overproduction of its toxic amyloid metabolites.
Key words:
Alzheimer's disease; caveolin; presenilin; amyloid
precursor protein; secretase; astrocyte
Copyright © 1999 Society for Neuroscience 0270-6474/99/19156538-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. I. Boulware, H. Kordasiewicz, and P. G. Mermelstein
Caveolin Proteins Are Essential for Distinct Effects of Membrane Estrogen Receptors in Neurons
J. Neurosci.,
September 12, 2007;
27(37):
9941 - 9950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Wood, J. S. Nye, N. J. C. Lamb, A. Fernandez, and M. Kitzmann
Intracellular Retention of Caveolin 1 in Presenilin-deficient Cells
J. Biol. Chem.,
February 25, 2005;
280(8):
6663 - 6668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kametaka, M. Shibata, K. Moroe, S. Kanamori, Y. Ohsawa, S. Waguri, P. J. Sims, K. Emoto, M. Umeda, and Y. Uchiyama
Identification of Phospholipid Scramblase 1 as a Novel Interacting Molecule with beta -Secretase (beta -Site Amyloid Precursor Protein (APP) Cleaving Enzyme (BACE))
J. Biol. Chem.,
April 18, 2003;
278(17):
15239 - 15245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-Y. Zhao, Y. Liu, R.-V. Stan, L. Fan, Y. Gu, N. Dalton, P.-H. Chu, K. Peterson, J. Ross Jr., and K. R. Chien
Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice
PNAS,
August 20, 2002;
99(17):
11375 - 11380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Chochina, N. A. Avdulov, U. Igbavboa, J. P. Cleary, E. O. O'Hare, and W. G. Wood
Amyloid {beta}-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region
J. Lipid Res.,
August 1, 2001;
42(8):
1292 - 1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Smart, G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti
Caveolins, Liquid-Ordered Domains, and Signal Transduction
Mol. Cell. Biol.,
November 1, 1999;
19(11):
7289 - 7304.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-Y. Park, J.-S. Park, K.-A Cho, D.-I. Kim, Y.-G. Ko, J.-S. Seo, and S. C. Park
Up-regulation of Caveolin Attenuates Epidermal Growth Factor Signaling in Senescent Cells
J. Biol. Chem.,
June 30, 2000;
275(27):
20847 - 20852.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|